94% Report Chronic Pain Relief With Medical Marijuana, New Study From Florida Shows

94% Report Chronic Pain Relief With Medical Marijuana, New Study From Florida Shows

Key Takeaways

  • A University of Florida study found that 94% of chronic pain patients reported pain relief from Florida medical marijuana.
  • Researchers divided 632 participants based on their primary use of medical marijuana, revealing important insights into chronic pain management.
  • 38% of opioid users reduced their intake, while 43% stopped opioids entirely after starting medical marijuana, indicating potential benefits.
  • Patients primarily found relief with flower (57%), vape products (44%), and edibles (43%), mostly favoring THC-dominant options.
  • Mild side effects occurred, including dry mouth, fatigue, and insomnia, with chronic pain patients reporting more than those using cannabis for other conditions.

Researchers from the University of Florida’s Department of Epidemiology set out to understand how medical marijuana patients experience chronic pain treatment. Their findings, published October 30th in the journal Cannabis, draw on data from the Medical Marijuana & Me survey, a project that collected responses from certified medical marijuana patients across ten clinics statewide.

The research team, led by Kendall R. Robinson along with Jennifer Jean Jacques, Robert L. Cook, and Yan Wang, split 632 participants into two groups: 278 patients who listed chronic pain as a main reason for using medical marijuana, and 354 patients using it primarily for other conditions. Comparing these groups let researchers isolate patterns specific to pain management rather than cannabis use in general.

This kind of condition specific data matters because most prior Florida cannabis research looked at patients as one broad group. By separating chronic pain patients from everyone else, the study offers a clearer picture of what this population actually experiences, which products they reach for, and how cannabis fits alongside other treatments like prescription opioids.

How Many Medical Marijuana Patients Reported Pain Relief?

Among the 278 participants who used medical marijuana primarily for chronic pain, 260 patients, or 94%, said their pain improved. Just 0.4% reported their pain got worse.

Patients who found relief were also asked which product type worked best for them. Three options stood out:

  • Flower, chosen by 57% of respondents
  • Vape products, chosen by 44%
  • Edibles, chosen by 43%

Topicals, tinctures, and concentrates were used less frequently but still played a role for some patients. Most people who found flower, vape, or edibles effective also leaned toward THC-dominant products rather than CBD-heavy or balanced options, a pattern that held across nearly every product category in the study.

Did Medical Marijuana Help Patients Cut Back on Opioids?

One of the more notable parts of the study looked at opioid use among patients who had taken prescription pain medication in the previous five years. Of 231 participants who reported opioid use, 209 answered a follow-up question about whether their opioid use changed after starting medical marijuana.

38% said they reduced their opioid use, and another 43% said they stopped taking opioids entirely. Combined, roughly 81% of these patients either cut back or discontinued opioids after adding medical marijuana to their routine.

The researchers were careful to note that these changes were self-reported and not independently confirmed through pharmacy or prescription records. Still, the numbers align with other research suggesting medical marijuana may help some patients reduce reliance on opioid medications, even though the evidence across the broader scientific literature remains mixed.

What Side Effects Did Chronic Pain Patients Report?

Side effects were generally described as mild. Across the full sample, the most common were dry mouth (26%), fatigue or low energy (24%), and insomnia (22%).

Patients in the chronic pain group reported several side effects more often than those using cannabis for other conditions, including dry mouth, fatigue, nausea, headaches, and numbness or tingling. None of these were flagged as severe, and the researchers noted that this pattern is consistent with earlier findings suggesting medical marijuana tends to be more tolerable than many conventional pain medications.

Who Were the Patients in This Florida Medical Marijuana Study?

Patients using medical marijuana for chronic pain tended to be older than those using it for other conditions. Just over 54% of the chronic pain group was age 50 or older, compared to about 31% among patients managing other conditions.

Chronic pain patients were also more likely to be using medical marijuana for medical rather than recreational reasons, and more likely to have Medicare coverage. Patients without insurance were less likely to report chronic pain as their main reason for using cannabis, a finding the researchers suggest may reflect barriers to accessing broader pain care options.

Most demographic factors, including race, education, and income, showed no significant difference between the two groups, suggesting that chronic pain patients in Florida’s medical marijuana program look fairly similar to the overall patient population aside from age and insurance status.

What Does This Mean for Florida Medical Marijuana Patients?

This study adds real data to a conversation that’s often driven by anecdote. A 94% relief rate among chronic pain patients is a meaningful number, and the opioid reduction findings point to why so many Florida patients turn to medical marijuana as part of their pain management plan.

That said, the researchers were upfront about the limits of their work. The sample was drawn from patients already enrolled in Florida’s program, product and dosing details relied on self-report, and the study didn’t track patients over time. They called for longitudinal research to better understand dosing and long-term outcomes, which is a fair point for anyone reading the headline number and wanting the full picture.

For now, the takeaway is encouraging for patients exploring medical marijuana for chronic pain, and it gives physicians and dispensary staff more specific information about which products patients with chronic pain actually find effective.

Frequently Asked Questions

What percentage of medical marijuana patients found pain relief in the Florida study?

According to the University of Florida study, 94% of patients who used medical marijuana primarily for chronic pain reported their pain improved, while only 0.4% said it got worse.

Which medical marijuana products worked best for chronic pain in the study?

Patients named flower (57%), vape products (44%), and edibles (43%) as the most effective options for managing chronic pain, with most favoring THC-dominant formulations.

Did medical marijuana reduce opioid use among Florida patients?

Yes. Among patients who had used prescription opioids in the past five years, about 81% reported either reducing or completely stopping opioid use after starting medical marijuana.

Were there side effects reported in the medical marijuana chronic pain study?

Most reported side effects were mild, with dry mouth, fatigue, and insomnia being the most common among all participants in the Florida medical marijuana study.

Who conducted the Florida medical marijuana chronic pain study?

The study was conducted by researchers at the University of Florida’s Department of Epidemiology, led by Kendall R. Robinson, and published in the journal Cannabis on October 30, 2026.


Join for Latest News & More

One email every Friday covering what’s really happening in our space. Business, culture, policy, and people, without the PR spin or recycled headlines.

You May Also Like

Come Back Again

You must be over 21 years of age to view this website.